Demand for staff in pharmacovigilance jobs is on the increase in India due to the growth of the pharmaceutical industry in the area.
Management consulting firm Accenture and the Institute of Clinical Research in India (ICRI) have stated that pharmacovigilance strategies are becoming vital to companies in order to test the safety of the rising number of drugs being produced in India.
The suggestion came after the two organisations announced plans to develop a joint pharmacovigilance and clinical research programme in the region to train and offer qualifications to local staff.
Manish Sharma Lead, of Accenture's service delivery operations, said: "India is emerging as a hub for clinical research and the demand for professionals in this field is growing rapidly."
Earlier this month, Quintiles told Genetic Engineering & Biotechnology News that pharmaceutical companies are increasing their presence across Asia in recent years.
Quintiles India chief executive officer Dr Ferzaan Engineer explained that this is due to the emergence of innovative research and development models, as well as the presence of favourable regulatory conditions.